Efficacy of Two Interventions Increasing Sensory Stimulus in Elderly Patients With Oropharyngeal Dysphagia
Launched by HOSPITAL DE MATARÓ · Jan 4, 2013
Trial Information
Current as of May 03, 2025
Completed
Keywords
ClinConnect Summary
This study will evaluate with videofluoroscopy (radiologic method to study the deglutitive physiology) the effect on the deglutition of two therapeutic treatments with the duration of 2 weeks, based on the increase of the sensorial stimuli in older patients with oropharyngeal dysphagia:
1. Stimulation of Transient Receptor Potential Vanilloid 1 (TRPV1) oropharynx chanels using a natural agonist administrated in the alimentary bolus.
2. Stimulation of the sensorial neurons of the pharynx and larynx using transcutaneous electrical stimuli.
The study will last 5 weeks per patient. At the beg...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Elderly patients (≥70 years) with oropharyngeal dysphagia (OD)
- • Patients have to fill in and sign the written informed consent.
- • Patients without any of the exclusion criteria.
- Exclusion Criteria:
- • Patients not able to comply with the protocol.
- • Patients currently participating or having participated in another clinical trial in the last 4 weeks.
- • Patients with active neoplasia.
- • Patients with an active infectious process.
- • Patients with severe dementia or inability to communicate.
- • Patients with pacemakers.
- • Patients with implanted electrodes.
- • Patients with epilepsy or convulsive disorders.
- • Patients with gastroesophageal reflux disease.
About Hospital De Mataró
Hospital de Mataró is a leading healthcare institution located in Mataró, Spain, dedicated to advancing medical research and improving patient care through clinical trials. As a prominent sponsor of clinical studies, the hospital fosters innovative research initiatives that aim to evaluate new treatments and therapies across various medical fields. With a commitment to ethical standards and patient safety, Hospital de Mataró collaborates with multidisciplinary teams of healthcare professionals and researchers to contribute to the global body of medical knowledge while enhancing the health outcomes of the communities it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mataró, Barcelona, Spain
Patients applied
Trial Officials
Omar Ortega Fernández, MSc
Principal Investigator
Hospital de Mataró
Pere Clavé, MD, PhD
Study Director
Hospital de Mataró
Laia Rofes, MSc
Principal Investigator
Hospital de Mataró
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials